Rare Congenital Bleeding Disorders – Challenges Remain

Hamostaseologie 2025; 45(05): 371-372
DOI: 10.1055/a-2698-0400

Editorial

Authors

Katharina Holstein

¹Institute for Clinical Chemistry, University Medical Center Schleswig-Holstein, Coagulation Centre, Kiel, Germany
Barbara Zieger

²Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Freiburg, Germany

References
1 Holstein K, Gutensohn K, Alesci RS, Krause M, Scholz U, Wermes C, Halimeh S. Overview on rare congenital bleeding disorders and epidemiological data from the German Haemophilia Registry (DHR) and a survey in Germany, Austria and Switzerland. Hamostaseologie 2025; 45: 378-389
2 Casini A, de Moerloose P. Management of young and ageing women with afibrinogenemia and hypofibrinogenemia. Hamostaseologie 2025; 45: 390-395
3 Raharimanana A, Cunat S, Falaise C, Oudot C, Fournel A, Dargaud Y. Hereditary combined deficiency of the vitamin K-dependent coagulation factors. Hamostaseologie 2025; 45: 396-404
4 Pezeshkpoor B, Banchev A, Preisler B. et al. Understanding congenital FXI deficiency: Genetic diagnosis and factor XI activity correlations. Hamostaseologie 2025; 45: 405-413
5 Böckelmann D, Friman T, Glonegger H, Wartiovaara-Kautto U, Zieger B. Late diagnosis of NBEAL2-related gray platelet syndrome in Finnish siblings with lifelong thrombocytopenia. Hamostaseologie 2025; 45: 414-418
6 Dreier T, Mehic D, Gebhardt J. Usefulness of global coagulation tests, thrombin generation and viscoelastic tests for assessing the bleeding phenotype in rare coagulation factor deficiencies. Hamostaseologie 2025; 45: 419-430